BC
BMO Capital Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
701
Green Plains
GPRE
$698M
|
KZ
Kenneth Zaslow
| $10.64 | $31 |
191%
upside
| Market Perform |
24 Oct ‘22
2 years ago |
|
702
Replimune Group
REPL
$494M
|
ES
Evan Seigerman
| $6.33 | $40 |
532%
upside
| Outperform |
14 Oct ‘22
2 years ago |
|
|
GMRE
703
Global Medical REIT
GMRE
$508M
|
JK
John Kim
| $7.60 | $9 |
18%
upside
| Market Perform |
6 Oct ‘22
2 years ago |
|
704
Sandstorm Gold
SAND
$3.37B
|
RC
Rene Cartier
| $11.48 | $8 |
30%
downside
| Outperform |
5 Oct ‘22
2 years ago |
|
705
Broadstone Net Lease
BNL
$3.53B
|
JK
John Kim
| $18.68 | $19 |
2%
upside
| Outperform |
27 Sep ‘22
2 years ago |
|
706
General Mills
GIS
$27B
|
KZ
Kenneth Zaslow
| $50.58 | $85 |
68%
upside
| Market Perform |
22 Sep ‘22
3 years ago |
|
707
Stitch Fix
SFIX
$737M
|
SS
Simeon Siegel
| $5.65 | $5 |
12%
downside
| Market Perform |
21 Sep ‘22
3 years ago |
|
708
Alnylam Pharmaceuticals
ALNY
$59.2B
|
GN
Gary Nachman
| $452 | $200 |
56%
downside
| Market Perform |
9 Sep ‘22
3 years ago |
|
709
Eli Lilly
LLY
$652B
|
EDS
Evan David Seigerman
| $727.21 | $396 |
46%
downside
| Outperform |
6 Sep ‘22
3 years ago |
|
710
Park Hotels & Resorts
PK
$2.4B
|
AK
Ari Klein
| $12 | $18 |
50%
upside
| Market Perform |
16 Aug ‘22
3 years ago |
|
711
Trane Technologies
TT
$92.1B
|
JT
Joel Tiss
| $413.83 | $180 |
57%
downside
| Outperform |
15 Aug ‘22
3 years ago |
|
712
PolyPid
PYPD
$54.8M
|
GN
Gary Nachman
| $3.45 | $750 |
21,639%
upside
| Outperform |
11 Aug ‘22
3 years ago |
|
713
Pediatrix Medical
MD
$1.49B
|
MB
Matt Borsch
| $17.07 | $23 |
35%
upside
| Market Perform |
10 Aug ‘22
3 years ago |
|
714
Bausch Health
BHC
$2.72B
|
GN
Gary Nachman
| $7.35 | $8 |
9%
upside
| Market Perform |
10 Aug ‘22
3 years ago |
|
715
Dominion Energy
D
$49.7B
|
JN
James Naklicki
| $58.19 | $91 |
56%
upside
| Outperform |
9 Aug ‘22
3 years ago |
|
716
Encompass Health
EHC
$12.6B
|
MB
Matt Borsch
| $125.58 | $65 |
48%
downside
| Outperform |
4 Aug ‘22
3 years ago |
|
717
Regeneron Pharmaceuticals
REGN
$60.8B
|
ES
Evan Seigerman
| $573.38 | $788 |
37%
upside
| Outperform |
4 Aug ‘22
3 years ago |
|
718
Jazz Pharmaceuticals
JAZZ
$7.86B
|
GN
Gary Nachman
| $129.50 | $188 |
45%
upside
| Outperform |
4 Aug ‘22
3 years ago |
|
719
Nuvation Bio
NUVB
$1.33B
|
ES
Evan Seigerman
| $3.90 | $2.50 |
36%
downside
| Market Perform |
2 Aug ‘22
3 years ago |
|
720
Kinross Gold
KGC
$26.9B
|
JP
Jackie Przybylowski
| $22.11 | $6 |
73%
downside
| Outperform |
28 Jul ‘22
3 years ago |
|
721
Howard Hughes
HHH
$4.69B
|
JK
John Kim
| $78.88 | $90 |
14%
upside
| Outperform |
26 Jul ‘22
3 years ago |
|
722
UnitedHealth
UNH
$286B
|
MB
Matt Borsch
| $315.39 | $610 |
93%
upside
| Market Perform |
20 Jul ‘22
3 years ago |
|
723
Netflix
NFLX
$529B
|
DS
Daniel Salmon
| $1,243.82 | $365 |
71%
downside
| Outperform |
14 Jul ‘22
3 years ago |
|
724
HCA Healthcare
HCA
$98.5B
|
MB
Matt Borsch
| $420.77 | $160 |
62%
downside
| Underperform |
6 Jul ‘22
3 years ago |
|
725
Universal Health Services
UHS
$12.1B
|
MB
Matt Borsch
| $190.12 | $90 |
53%
downside
| Underperform |
6 Jul ‘22
3 years ago |
|